CAM
EW icon

Cidel Asset Management’s Edwards Lifesciences EW Stock Holding History

Cidel Asset Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$227K Buy
+2,511
New +$210K 0.01% 424
2019
Q4 		– Sell
-27,012
Closed -$1.98M – 116
2019
Q3 		$1.98M Buy
+27,012
New +$1.9M 0.1% 63

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Cidel Asset Management's EW Position: Q2 2026 in Review

Cidel Asset Management opened a new position in Edwards Lifesciences (EW) in Q2 2026: 2,511 shares worth $227K. The stake represents 0.01% of the portfolio and ranks #424 among its holdings. This is a return to the name: Cidel Asset Management previously reported a position in EW as recently as Q3 2019.

Cidel Asset Management first reported a position in EW in Q3 2019 and has held it in 2 quarters since. The position peaked at $1.98M in Q3 2019. 357 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Cidel Asset Management held 2,511 shares of Edwards Lifesciences worth $227K as of Q2 2026.
  • Edwards Lifesciences was a new Cidel Asset Management position in Q2 2026.
  • Edwards Lifesciences made up 0.01% of Cidel Asset Management's portfolio in Q2 2026, its #424 holding.
  • Cidel Asset Management first reported a position in Edwards Lifesciences in Q3 2019 and has held it in 2 quarters since.
  • Cidel Asset Management's Edwards Lifesciences position peaked at $1.98M in Q3 2019.
  • 357 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Cidel Asset Management's 13F filing for Q2 2026, filed 17 Jul 2026.